Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
Clinical trial NCT02858492 · COMPLETED
Trial details
- NCT number
- NCT02858492
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-17
- Primary completion
- 2018-10-22
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.